- Home
- BB vs VCEL Comparison
BB vs VCEL Comparison
Compare BB & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BB
- VCEL
- Stock Information
- Founded
- BB 1984
- VCEL 1989
- Country
- BB Canada
- VCEL United States
- Employees
- BB N/A
- VCEL N/A
- Industry
- BB
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BB
- VCEL Health Care
- Exchange
- BB Nasdaq
- VCEL Nasdaq
- Market Cap
- BB 2.2B
- VCEL 2.1B
- IPO Year
- BB 1997
- VCEL 1997
- Fundamental
- Price
- BB $3.86
- VCEL $36.36
- Analyst Decision
- BB Buy
- VCEL Strong Buy
- Analyst Count
- BB 6
- VCEL 7
- Target Price
- BB $4.64
- VCEL $61.29
- AVG Volume (30 Days)
- BB 7.1M
- VCEL 531.1K
- Earning Date
- BB 09-25-2025
- VCEL 07-31-2025
- Dividend Yield
- BB N/A
- VCEL N/A
- EPS Growth
- BB N/A
- VCEL 2045.40
- EPS
- BB N/A
- VCEL 0.13
- Revenue
- BB $533,200,000.00
- VCEL $249,119,000.00
- Revenue This Year
- BB $2.17
- VCEL $18.35
- Revenue Next Year
- BB $7.03
- VCEL $22.47
- P/E Ratio
- BB N/A
- VCEL $272.26
- Revenue Growth
- BB 4.65
- VCEL 16.13
- 52 Week Low
- BB $2.22
- VCEL $33.09
- 52 Week High
- BB $6.24
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- BB 51.58
- VCEL 47.46
- Support Level
- BB $3.78
- VCEL $35.18
- Resistance Level
- BB $3.93
- VCEL $36.87
- Average True Range (ATR)
- BB 0.10
- VCEL 1.37
- MACD
- BB 0.03
- VCEL 0.14
- Stochastic Oscillator
- BB 68.95
- VCEL 51.27
About BB BlackBerry Limited
BlackBerry, once known for being the world's largest smartphone manufacturer, is now exclusively a software provider with a stated goal of end-to-end secure communications for enterprises. The firm provides endpoint management and other secure communications software to enterprises, specializing in regulated industries like government and financial institutions. BlackBerry also has a sizable embedded software business primarily serving the automotive market, with some exposure to the industrial market.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.